These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18037105)

  • 21. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
    Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
    Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
    [No Abstract]   [Full Text] [Related]  

  • 22. Emphasis should be placed on the diagnosis and therapy of tumor induced osteomalacia.
    Wang XL; Mu YM
    Chin Med J (Engl); 2011 Jan; 124(2):163-5. PubMed ID: 21362358
    [No Abstract]   [Full Text] [Related]  

  • 23. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases.
    Feng J; Jiang Y; Wang O; Li M; Xing X; Huo L; Li F; Yu W; Zhong DR; Jin J; Liu Y; Qi F; Lv W; Zhou L; Meng XW; Xia WB
    Endocr J; 2017 Jul; 64(7):675-683. PubMed ID: 28450684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.
    Takeuchi Y; Suzuki H; Ogura S; Imai R; Yamazaki Y; Yamashita T; Miyamoto Y; Okazaki H; Nakamura K; Nakahara K; Fukumoto S; Fujita T
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3979-82. PubMed ID: 15292336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Jonsson KB; Zahradnik R; Larsson T; White KE; Sugimoto T; Imanishi Y; Yamamoto T; Hampson G; Koshiyama H; Ljunggren O; Oba K; Yang IM; Miyauchi A; Econs MJ; Lavigne J; Jüppner H
    N Engl J Med; 2003 Apr; 348(17):1656-63. PubMed ID: 12711740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hypophosphatemic osteomalacia].
    Bullmann C; Benker G; Rosien U; Delling G; Siggelkow H; Schulte HM
    Med Klin (Munich); 2008 Sep; 103(9):671-5. PubMed ID: 18813890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the Fibroblast Growth Factor 23 measurement in one patient].
    Dupond JL; Magy N; Mahammedi M; Prie D; Gil H; Meaux-Ruault N; Kantelip B
    Rev Med Interne; 2005 Mar; 26(3):238-41. PubMed ID: 15777586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.
    Fukumoto S; Yamashita T
    N Engl J Med; 2003 Jul; 349(5):505-6; author reply 505-6. PubMed ID: 12892105
    [No Abstract]   [Full Text] [Related]  

  • 29. Hypophosphatemia: A Practical Guide to Evaluation and Management.
    Tebben PJ
    Endocr Pract; 2022 Oct; 28(10):1091-1099. PubMed ID: 35940468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
    Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
    BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
    Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
    Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypophosphatemia and tumor-induced osteomalacia].
    van der Rest C; Cavalier E; Colson L; Kaux JF; Krzesinski JM; Reginster JY; Hustinx R; Delanaye P
    Rev Med Suisse; 2011 Aug; 7(306):1630-3. PubMed ID: 21972729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia.
    Kawarazaki H; Shibagaki Y; Shimizu H; Kawarazaki W; Ito N; Ishikawa A; Fukumoto S; Fujita T
    Clin Exp Nephrol; 2007 Sep; 11(3):255-257. PubMed ID: 17891358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-induced osteomalacia: The tumor may stay hidden!
    van der Rest C; Cavalier E; Kaux JF; Krzesinski JM; Hustinx R; Reginster JY; Delanaye P
    Clin Biochem; 2011 Oct; 44(14-15):1264-6. PubMed ID: 21843522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study.
    Kawarazaki H; Shibagaki Y; Fukumoto S; Kido R; Nakajima I; Fuchinoue S; Fujita T; Fukagawa M; Teraoka S
    Nephrol Dial Transplant; 2011 Aug; 26(8):2691-5. PubMed ID: 21303965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation.
    van Husen M; Lehnhardt A; Fischer AK; Brinkert F; Loos S; Oh J; Kemper MJ
    Pediatr Transplant; 2012 Aug; 16(5):443-50. PubMed ID: 22554017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperparathyroidism Which Developed after Resection of a Fibroblast Growth Factor 23-producing Tumor.
    Koikawa K; Okada Y; Torimoto K; Tanaka Y
    Intern Med; 2020 Oct; 59(20):2523-2527. PubMed ID: 32641663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic prostate cancer presenting as tumour-induced osteomalacia.
    Layman AAK; Joshi S; Shah S
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31315844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated serum FGF23 concentrations in plasma cell dyscrasias.
    Stewart I; Roddie C; Gill A; Clarkson A; Mirams M; Coyle L; Ward C; Clifton-Bligh P; Robinson BG; Mason RS; Clifton-Bligh RJ
    Bone; 2006 Aug; 39(2):369-76. PubMed ID: 16644301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
    Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.